ERDAFITINIB.
150 Inquiries
1346242-81-6
Shanghai
1g/bag
2026-06-25
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine
Other Name:1,2-Ethanediamine,N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-;N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine;Erdafitinib;JNJ 42756493;Balversa;1620332-47-9
CAS No.:1346242-81-6
Molecular Formula:C25H30N6O2
InChIKeys:InChIKey=OLAHOMJCDNXHFI-UHFFFAOYSA-N
Molecular Weight:446.54
Exact Mass:446.54
UNII:890E37NHMV
NCI Thesaurus Code:C103273
ATC Code:L - Antineoplastic and immunomodulating agents
Categories:
Characteristics-
PSA:
77.3
XLogP3:3.2
Density:1.2±0.1 g/cm3
Flash Point:354.4±31.5 °C
Refractive Index:1.618
Water Solubility:<1 mg/mL
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Skin sensitization, Sub-category 1B
Serious eye damage, Category 1
Reproductive toxicity, Category 2
Specific target organ toxicity â repeated exposure, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H317 May cause an allergic skin reaction
H318 Causes serious eye damage
H361 Suspected of damaging fertility or the unborn child
H372 Causes damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P272 Contaminated work clothing should not be allowed out of the workplace.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P203 Obtain, read and follow all safety instructions before use.
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P333+P317 If skin irritation or rash occurs: Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History150 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Hot Selling ERDAFITINIB 1346242-81-6 Factory Supply Raw Materials High Qulity Wholesale price
3 MT Jul 5, 2026 
Australia
Erdafitinib
1 G Jul 18, 2026 
Cyprus
Erdafitinib
1 G Jul 22, 2026 
Bulgaria
Erdafitinib
500 MG Jun 18, 2026 
Switzerland
1g Erdafitinib raw powder >99% purity
1 G May 22, 2026 
Romania
erdafitinib
1 G Jul 23, 2026 
France
Erdafitinib
1 KG Jul 23, 2026
United States
erdafitinib
1 G Jul 23, 2026 
Norway
Erdafitinib
1 G Jul 23, 2026 
Italy
Erdafitinib
1 G Jul 22, 2026
United States
erdafitinib
1 G Jul 21, 2026
United States
Erdafitinib
1 G Jul 21, 2026 
United Kingdom
Erdafitinib Powder
1 G Jul 20, 2026
United States
Erdafitinib
3 G Jul 19, 2026 
Turkey
Erdafitnib
1 G Jul 14, 2026
United States
erdafitinib
1 G Jul 12, 2026 
Colombia
High Quality Erdafitinib 99% powder 1346242-81-6-Shaanxi Dideu Medichem Co.Ltd
1 G Jul 11, 2026
Australia
High Quality Erdafitinib 99% powder
300 MG Jul 10, 2026 
Poland
erdafinib 99%
1 G Jul 8, 2026 
Denmark
Erdafitinib
1 G Jul 8, 2026 Post an enquiry for this product